0.2599
0.26 (-3.08%)
As of Mar 06, 2024
Matinas Biopharma Holdings, Inc. [MTNB]
Source:
Company Overview
Matinas Biopharma Holdings, Inc focused on redefining the intracellular delivery of nucleic acids and small molecules through our lipid nanocrystal (LNC) drug deliveryplatform and its application to overcome current challenges in safely and effectively delivering small molecules, nucleic acids, genetherapies, proteins/peptides, and vaccines.
Country | United States |
Headquarters | bedminster, new jersey |
Phone Number | 908-484-8805 |
Industry | manufacturing |
CEO | Jerome D. Jabbour |
Website | www.matinasbiopharma.com |